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Abstract
CR3 and CR4, the leukocyte specific β2-integrins, involved in cellular adherence, migration
and phagocytosis, are often assumed to have similar functions. Previously however, we
proved that under physiological conditions CR4 is dominant in the adhesion to fibrinogen of
human monocyte-derived macrophages (MDMs) and dendritic cells (MDDCs). Here, using
inflammatory conditions, we provide further evidence that the expression and function of
CR3 and CR4 are not identical in these cell types. We found that LPS treatment changes
their expression differently on MDMs and MDDCs, suggesting a cell type specific regulation.
Using mAb24, specific for the high affinity conformation of CD18, we proved that the activa-
tion and recycling of β2-integrins is significantly enhanced upon LPS treatment. Adherence
to fibrinogen was assessed by two fundamentally different approaches: a classical adhesion
assay and a computer-controlled micropipette, capable of measuring adhesion strength.
While both receptors participated in adhesion, we demonstrated that CR4 exerts a dominant
role in the strong attachment of MDDCs. Studying the formation of podosomes we found
that MDMs retain podosome formation after LPS activation, whereas MDDCs lose this abil-
ity, resulting in a significantly reduced adhesion force and an altered cellular distribution of
CR3 and CR4. Our results suggest that inflammatory conditions reshape differentially the
expression and role of CR3 and CR4 in macrophages and dendritic cells.
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Introduction
The complement receptors CR3 (CD11b/CD18, also known as Mac-1; αMβ2) and CR4
(CD11c/CD18, also known as p150,95; αXβ2) belong to the family of β2-integrins and play an
important role in phagocytosis, cellular adherence and migration [1]. Their ligands include
iC3b, the activation product of complement component C3, present on opsonized targets, as
well as the adhesion ligands fibrinogen and ICAM-1 [2–4]. The ligand binding affinity of
integrins is regulated by activation dependent conformational changes. Their extracellular
domains undergo remarkable structural rearrangements during the switch from a bent, inac-
tive state into an extended, ligand-binding conformation [5,6].
Based on findings showing that CR3 and CR4 have overlapping ligand binding specificity
and share 87% sequence homology in their extracellular domains [7], these two receptors are
generally assumed to exert similar functions. However, their intracellular tails, important for
signal transduction and connection with the cytoskeleton, markedly differ in length and
amino acid sequence—displaying only 56% similarity [8] -, suggesting distinctive functions for
these receptors. Our group was the first to comprehensively study the individual role of CR3
and CR4 in various functions of different human phagocytes [9,10]. We proved that there is a
“division of labor” between these two receptors under physiological conditions. Namely, we
demonstrated that CR3 is in control of the phagocytosis of iC3b opsonized bacteria while CR4
dominates cell adhesion to fibrinogen [11–13].
Fibrinogen, a major ligand of β2-integrins, is an acute phase reactant, which is a key regula-
tor of inflammation in disease [14]. It deposits at the sites of injury and contributes to the
inflammatory response by participating in the adhesion and migration of leukocytes. By their
interaction with fibrinogen [15,16], CR3 and CR4 are known to facilitate cell activation, cyto-
kine and chemokine production [17,18]. Although an elevated expression of CR3 and CR4 has
been observed in pathological conditions [19,20], their exact role in human macrophages and
dendritic cells has not been studied in detail under inflammatory conditions. The lack of this
knowledge prompted us to investigate the adhesive and migratory function of these β2-integ-
rins in the inflammatory response induced by LPS.
Myeloid cells achieve movement by forming podosomes, that are adhesive structures hav-
ing an F-actin core surrounded by adhesion molecules, like integrins [21,22]. Podosomes also
sense the rigidity and structure of their environment, and help cell progression through the
degradation of matrix components with matrix metalloproteinases and ADAMs (a disintegrin
and metalloproteinase) [23,24]. The crucial role of β2-integrins in podosome formation is well
established [25,26] and our group also showed earlier that both CR3 and CR4 are present in
the adhesion ring of podosomes formed by monocyte-derived macrophages (MDMs) and den-
dritic cells (MDDCs) on a fibrinogen coated surface [12].
Recent studies have shown, that M1 macrophages–i.e. cells activated by LPS and IFNγ -
express CCR7 and migrate in the direction of CCL19 and CCL21 chemokine gradient [27],
which results in their accumulation at the inflammatory sites [28,29]. Dendritic cells are
known to migrate to the lymph nodes after antigen uptake, and during this journey they go
through a maturation process [30]. Maturation induces changes in chemokine receptor
expression [31], including CCR7, which appears 3 hours after the inflammatory stimulus, and
becomes more pronounced after 12–24 hours [32]. The maturation of dendritic cells is also
accompanied by dynamic changes in the actin cytoskeleton, that entails decreased phagocyto-
sis and the loss of podosome formation [25,33,34].
Our group set out to thoroughly investigate how CR3 and CR4 participate in leukocyte
functions necessary for the resolution of infections. To better understand these processes, our
aim was to reveal the role of CR3 and CR4 in adhesion and migration during the inflammatory
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response and to extend these studies by investigating the force of adhesion and the distribution
of CR3 and CR4 in the contact zone of macrophages and dendritic cells after LPS-treatment.
Materials and methods
Isolation of human monocytes
Monocytes were isolated from buffy coat obtained from healthy donors and delivered by the
Hungarian National Blood Transfusion Service. Informed consent was provided for the use of
blood samples. The study was carried out in accordance with the Helsinki Declaration and was
approved by the Ethics Committee of the Medical Research Council in Hungary (TUKEB),
52088/2015/EKU. Peripheral blood mononuclear cells (PBMC) were separated by Ficoll-
Paque PLUS (GE Healthcare Bio-Science, Uppsala, Sweden) density gradient centrifugation
and monocytes were isolated using the Miltenyi CD14 MicroBeads (Miltenyi Biotech, Bergisch
Gladbach, Germany). Purity of isolated monocytes was analyzed by flow cytometry using anti-
CD14 antibody (ImmunoTools GmbH, Friesoythe, Germany).
Generation of MDMs and MDDCs
Monocytes were cultivated in RPMI-1640 Medium (Sigma-Aldrich Inc., St Louis, MO, USA)
supplemented with gentamicin (Sigma-Aldrich) and 10% FCS (Sigma-Aldrich). To generate
MDMs 40 ng/ml rHu GM-CSF (R&D systems, Minneapolis, USA) was added to the isolated
monocytes. To generate MDDCs 40 ng/ml rHu GM-CSF (R&D systems) and 15 ng/ml rHu
IL-4 (R&D systems) were added to the monocytes. Cytokines were resupplied on day 3 of dif-
ferentiation. Studies were carried out on day 5.
Induction of inflammatory condition using LPS treatment
MDMs and MDDCs were treated with 100 ng/ml bacterial lipopolysaccharide (LPS, Sigma-
Aldrich) on the 5th day of differentiation to induce cell activation. Cells were cultured in
12-well cell culture plates at 106 cells/ml with LPS or without LPS (untreated control) for dif-
ferent time periods.
Monitoring the expression of CD11b and CD11c during LPS induced
activation
The expression of CD11b and CD11c was measured by flow cytometry at different time points
during the LPS induced cell activation. LPS treated and untreated control cells were harvested
after 30 minutes, 24 hours or 48 hours, and washed with ice cold PBS (phosphate buffered
saline solution) supplemented with 0.4% sodium azide and 1% FCS. Cells were labelled with
anti-CD11b-FITC and anti-CD11c-APC (ImmunoTools GmbH) for 20 minutes on ice. The
expression of the receptors was compared to the appropriate untreated control sample at each
time point. Samples were analyzed on Cytoflex flow cytometer (Beckman Coulter) using
CytExpert software for data acquisition and Kaluza Analysis software for data analysis.
Analysis of β2-integrin conformational state
The conformation state of β2-integrins was determined using the activation epitope specific
mouse monoclonal mAb24 antibody labelled with Alexa488 (BioLegend, San Diego, Califor-
nia, USA). 5x105 cells were resuspended in 400 μl of RPMI-1640 medium and labelled with
mAb24-Alexa488 antibody for 20 minutes on ice under sterile conditions. Without washing,
the tubes were moved to a 37˚C CO2 incubator or left on ice (0-minute controls). To induce
activation, 100 ng/ml LPS was added to the cells at the beginning of the 37˚C incubation. After
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the incubation time cells were washed with ice cold PBS supplemented with 0.4% sodium
azide and 1% FCS and put on ice immediately, to stop the receptor internalization. Samples
were analyzed on Cytoflex flow cytometer at 0 minutes and 30 minutes. Confocal microscopy
images were prepared at 0, 5 and 30 minutes by Olympus IX81 confocal microscope (60x
objective) and FluoView500 software.
Blocking of CD11b/CD18 and CD11c/CD18 by antibodies
The role of CD11b/CD18 and CD11c/CD18 in the adhesion to fibrinogen was analyzed by
comparing the adhesive properties of MDMs and MDDCs treated with either 50 μg/ml anti-
CD11b antibody (monoclonal mIgG1 clone ICRF44, Biolegend) or 50 μg/ml anti-CD11c anti-
body (monoclonal mIgG1 clone 3.9, Biolegend). Both antibodies are specific for the ligand
binding domain of the corresponding integrin and were used in sterile, azide-free form at satu-
rating concentration previously titrated by flow cytometry. The effect of receptor specific anti-
bodies was compared to samples incubated with an isotype matched control antibody (mouse
IgG1 clone MOPC-21, Biolegend). To exclude Fc-receptor mediated binding of the blocking
monoclonal antibodies we used an Fc-receptor blocking reagent (Miltenyi Biotech) prior to
the antibody treatment. Cells were incubated with the receptor-specific antibodies for 30 min-
utes at 4˚C then used in the functional studies without washing, since unblocked integrins are
known to recycle and appear on the cell surface from an intracellular pool [35], that would
decrease the efficiency of receptor blocking.
Analysis of adhesion
Analysis of adhesion by confocal microscopy. The wells of a CELLview cell culture dish
with glass bottom (Greiner Bio-One, Kremsmünster, Austria) were coated with 10 μg/ml
fibrinogen (Merck, Darmstadt, Germany) in PBS for 1 hour at 37˚C, free surfaces were
blocked with synthetic copolymer poly (L-lysine)-graft-poly (ethylene glycol) (PLL-g-PEG,
SuSoS AG, Dübendorf, Switzerland) for 30 minutes at 37˚C.
The density of fibrinogen was titrated to a concentration that supported the highest number
of adherent cells. In a preliminary experiment we found that the number of fibrinogen ligands
on the adhesive surface is comparable with the total amount of receptors found on monocytes
(50x103 CD11b and 7x103 CD11c molecules on their surface) [9,11]. Since macrophages and
dendritic cell have far more of these receptors on their surface (in a range of 200-300x103), we
propose that this ligand density is suitable for the assessment of receptor usage.
After washing the wells twice with PBS, 4x104 cells, previously incubated with the blocking
antibodies as described above, were transferred to the wells and let to adhere for 30 minutes at
37˚C in a CO2 incubator. After the incubation, samples were fixed with 2% paraformaldehyde
(Sigma-Aldrich) for 10 minutes and unbound cells were removed by washing 2 times with
PBS. The number of adhered cells was determined by staining the nuclei with Draq5 (BioLe-
gend) diluted 1000x (5 μM) in PBS and incubated for 15 minutes at RT. Samples were analyzed
by Olympus IX81 confocal microscope (10x objective) and FluoView500 software. 10 repre-
sentative fields were scanned in each well, and the number of cells was determined using Ima-
geJ software.
Measuring the force of adhesion with the computer-controlled micropipette. The force
of adhesion on a fibrinogen coated surface was firstly compared between untreated control
cells and cells treated with LPS for 24 hours. Then, to determine the participation of CR3 and
CR4, the adhesion force was measured after blocking either CD11b or CD11c on LPS treated
MDMs and MDDCs.
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Single cell adhesion force was analyzed with an imaging-based automated micropipette
(CellSorter, Budapest, Hungary) as described previously [36,37]. Briefly, a 5 mm by 5 mm
PDMS insert (SYLGARD 184, Dow Corning, Midland, Michigan, USA) was placed in a Petri
dish and the surface was coated with 10 μg/ml fibrinogen in PBS for 1 hour at 37˚C. Dishes
were washed twice with PBS and the surface was blocked with 100 μg/ml synthetic copolymer
PLL-g-PEG (SuSoS AG), in order to inhibit non-specific cell adhesion, for 30 minutes at RT.
Dishes were incubated at 4˚C overnight, then washed with PBS. Afterwards, 2x104 cells in
RMPI-10% FCS were placed onto the coated surface and incubated for 30 minutes at 37˚C in a
5% CO2 atmosphere. Cultures were washed 2 times with Hanks’ Balanced Salt solution with
sodium bicarbonate without phenol red buffer (HBSS, Sigma-Aldrich) to remove floating
cells. Region of interest (ROI) of the Petri dish was scanned by a motorized microscope (Zeiss
Axio Observer A1) equipped with a digital camera (Qimaging Retiga 1300 cooled CCD). Cells
were automatically recognized by the CellSorter software. To minimize the duration of the
measurement, the shortest path of the micropipette was calculated by software [38]. Individual
cells were visited and probed by the glass micropipette. The micropipette with an aperture of
70 μm approached the surface to a distance of 10 μm. Vacuum was generated in a standard
syringe connected to the micropipette via a high speed normally closed fluid valve. To probe
cell adhesion the valve was opened for 20 ms generating a precisely controlled fluid flow and
corresponding hydrodynamic lifting force acting only on the targeted cell. The hydrodynamic
lifting force was calculated by running computer simulation solving the Navier-Stokes equa-
tion in a geometry corresponding to the experimental setup [37]. After each cycle of the adhe-
sion force measurement the ROI of the Petri dish was scanned again, and the vacuum was
increased to the next level. The micropipette visited again each location determined after the
initial scan. Suction force was increased as long as most of the cells were removed. The number
of cells were counted in the images before and after each cycle of the adhesion force measure-
ment and calculated the ratio of still adhering cells of the population placed onto the surface at
the beginning of the experiment.
Analysis of the contact surface by confocal microscopy
For the contact surface analysis 104 cells were plated on a fibrinogen coated surface as
described above.
Staining of the actin cytoskeleton and podosome counting. The actin cytoskeleton of
adhered cells was stained with phalloidin-Alexa488 (Molecular Probes, Invitrogen, Eugene,
Oregon, USA) diluted 1:80 in PBS-0.1% Triton X-100 (Reanal, Budapest, Hungary) for 15
minutes, then washed 2 times with PBS. Nuclei were stained with Draq5 (BioLegend) diluted
1:1000 (5 μM) in PBS for 15 minutes. Samples were analyzed by an Olympus IX81 confocal
microscope (60x objective) applying Fluowiev500 confocal workstation.
The number of podosomes was counted using the method described by Cervero et al. [39].
Briefly, the podosome number and contact zone area of the cells was determined using ImageJ
software. Podosome density of 40–60 cells/sample was calculated as the number of podosomes
per 100 μm2 cell covered area.
Staining of CD11b/CD11c on adherent cells. Fixed samples were permeabilized with
0.1% Tween-20 (Reanal) in PBS for 20 minutes at 37˚C. The permeabilizing solution was
replaced with a blocking solution: 0.2% gelatin (Merck) and 0.1% Tween-20 in PBS and cells
were incubated for 1 hour at 37˚C. Cells were incubated with the primary antibodies overnight
at 37˚C, followed by the secondary antibodies for 2 hours at 37˚C. The antibodies were diluted
in the blocking solution. Cells were washed with 0.1% Tween-20 in PBS 3 times for 5 minutes
each before adding the secondary antibody. Antibodies used for staining: anti-CD11b
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(EP1345Y, Abcam, Cambridge, UK), anti-CD11c (EP1347Y, Abcam), goat anti-rabbit IgG-A-
lexa647 (Molecular Probes). After the secondary antibody staining cells were washed 3 times
for 5 minutes each with 0.1% Tween-20 in PBS. The actin cytoskeleton was stained with phal-
loidin-Alexa488 (Molecular Probes) 1:80 diluted in 0.1% Tween-20 PBS for 45 minutes at
37˚C. Samples were analyzed by an Olympus IX81 confocal microscope (60x objective). For
better visibility the brightness and contrast of images was adjusted using Adobe Photoshop
CS3.
Analysis of transmigration
Migration of both untreated and LPS treated (24 hours) cells was analyzed using 24 well trans-
well plates (polycarbonate membrane with 5 μm pore, Corning, Corning, NY, USA). 105 cells
in 100 μl RPMI-1640 medium were plated in the upper chamber, and the lower chamber was
filled with 600 μl of chemoattractant solution or medium (negative control). For the untreated
cells 62.5 nM N-Formylmethionine-leucyl-phenylalanine (FMLP, Sigma-Aldrich) was used as
a chemoattractant and the migration was stopped after 1 hour. For the LPS treated cells we
used 200 ng/ml CCL19 (BioLegend), and the migration was stopped after 2 hours for MDDCs
and 4 hours for MDMs. At the end of the incubation time, EDTA was pipetted to the lower
chamber without removing the membrane, at a final concentration of 12.5 mM. After 5 min-
utes at 37˚C cells were resuspended from the lower chamber and the bottom of the membrane,
placed on ice and counted immediately. The number of transmigrated cells was determined in
a volume of 250 μl/sample by flow cytometry (Cytoflex, BC).
Statistics
Statistical tests (specified at the data presentation) were performed with GraphPad Prism 5
software, p<0.05 was considered significant. One-way ANOVA was used to compare three or
more sets of measurements when only one factor was changed during the experiment. Two-
way ANOVA was employed when the effect of two factors were examined simultaneously.
Results
Under inflammatory conditions CR3 and CR4 is expressed differently on
MDMs and MDDCs
The expression of CR3 and CR4 was monitored by flow cytometry at different time points dur-
ing the LPS induced cell activation. Comparing the amount of CR3 and CR4 on the cell surface
we found that LPS treatment alters their expression differently on MDMs and MDDCs (Fig 1).
Whereas on MDMs the expression of both CR3 and CR4 decreases, on MDDCs only the
expression of CR3 is diminished, CR4 appears at a significantly elevated level. Cytometry pro-
files of CR3 and CR4 expression after LPS treatment are shown in S1 Fig.
LPS treatment enhances β2-integrin cycling in both MDMs and MDDCs
The ligand binding affinity of β2-integrins is regulated by activation dependent conformational
changes, when these receptors switch between an inactive bent and an activated extended
structure. The conformational state of the receptors can be checked using the mouse monoclo-
nal mAb24 antibody, which is specific for an activation epitope in the I-like domain of the β2
chain (CD18). This determinant is revealed only in the activated, high affinity receptor with an
open conformation; therefore, this antibody does not bind to the receptors of cells kept on ice
(Fig 2A, 2D, 2H and 2I). Cells were incubated with the Alexa488 labelled mAb24 antibody for
20 minutes on ice, then, without washing, cells were moved to a 37˚C incubator. Under the
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experimental conditions that were used for our functional studies, the receptors were in an
active, open conformation, confirmed by the binding of the mAb24 antibody.
Confocal microscopy images showed an even distribution of β2-integrins in the cell mem-
brane after 5 minutes of incubation at 37˚C, whereas after 30 minutes the labelled receptors
started to accumulate inside the cell (Fig 2A–2G). The internalization of β2-integrins was con-
firmed with z-stack analysis (Fig 2G). Integrins are known to have a fast turnover between the
cell surface and intracellular pools, leading to the appearance of unlabeled receptors on the cell
surface, that bind the mAb24 antibody, increasing the fluorescence intensity with time. When
100 ng/ml LPS was added to the cells during the 37˚C incubation time, the mean fluorescence
intensity (MFI) was significantly higher, proving that LPS enhances the activation and turn-
over of β2-integrins (Fig 2H and 2I).
Under inflammatory conditions both CR3 and CR4 participate in the
adhesion to fibrinogen
We set out to study the participation of CR3 and CR4 in the adhesion of MDMs and MDDCs
to a fibrinogen coated surface first by a classical method, where the number of adherent cells
on a fibrinogen coated surface was counted. To distinguish the function of CR3 and CR4 in
adhesion under inflammatory conditions, cells were treated with either anti-CD11b or anti-
CD11c antibody prior to the assay. Unbound cells were washed away before counting. We
found that in the case of LPS treated MDMs and MDDCs both CR3 and CR4 participated in
cell adhesion, as blocking antibodies equally decreased the number of adherent cells compared
to the isotype control antibody treated samples (Fig 3A and 3B). The low inhibition observed
with this method can be attributed to the fibrinogen binding ability of other receptors, namely,
αVβ3 and α5β1 present on myeloid cells [40–42] and the high recyclization rate of β2 integrins
(shown on Fig 2) that might lower the efficiency of antibody blocking. However, the inhibition
by the specific antibodies proves that CR3 and CR4 contribute to the adhesion to fibrinogen
equally.
Fig 1. Changes in the expression of CR3 and CR4 after LPS induced activation. The surface expression of CR3 and CR4 was measured at different time
points by flow cytometry. The effect of 100 ng/ml LPS treatment was compared to the appropriate untreated control sample at each time point, shown as
100%. For MDMs (A) results of 3 donors (mean ± SD), for MDDCs (B) 4 donors’ results (mean ± SD) are shown. Two-way ANOVA with Bonferroni
post-test was used to determine significant differences compared to control, � = p< 0.05; �� = p< 0.01; ��� = p< 0.001.
https://doi.org/10.1371/journal.pone.0232432.g001
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LPS induced maturation decreases the force of adhesion significantly in
MDDCs
In this set of experiments, we evaluated cell adhesion to fibrinogen using a state-of-the-art bio-
physical method, which allows the measurement of the force of cell attachment with a com-
puter-controlled micropipette. Cells were let to adhere on a fibrinogen coated surface, and
their adhesion force was assessed by trying to pick them up with the micropipette using vac-
uum induced fluid flow. The pick-up process was repeated several times with increased vac-
uum, and cells remaining on the surface were counted after each cycle. Applied vacuum was
converted to force (nN) based on computer simulations. Employing the micropipette, we
observed a significantly reduced adhesion force for LPS treated MDDCs (Fig 3D). In the case
of LPS activated MDMs we observed only a slight decrease in the strength of attachment com-
pared to the untreated cells (Fig 3C).
CR4 is prominently involved in the strong attachment of MDMs and
MDDCs to fibrinogen
To differentiate the role of CR3 and CR4 in the adhesion to fibrinogen we blocked either
CD11b or CD11c by ligand binding site specific monoclonal antibodies. Experimental data are
presented as the ratio of blocking antibody treated adherent cells compared to the isotype con-
trol treated cells. Previously we proved, that under physiological conditions only the blocking
of CD11c decreased the adhesion force of MDMs and MDDCs, CD11b did not play a role in
cell attachment [11]. Here we demonstrate, that during inflammatory conditions, both recep-
tors become involved in adherence, however the blocking of CD11c resulted in a weaker
attachment of MDDCs compared to the anti-CD11b treated samples (Fig 3E and 3F).
MDDCs lose their podosomes during LPS induced maturation
Podosomes are adhesive structures known to mediate short-lived adhesion spots that are
formed and quickly remodeled during migration. Considering their importance in cell attach-
ment and movement, we set out to study their formation after LPS treatment by staining the
actin cytoskeleton with phalloidin-Alexa488. Cells were let to adhere on a fibrinogen coated
surface and nuclei were stained with Draq5 DNA dye. As it is demonstrated in Fig 4, panel C
and D, LPS treatment induced the loss of podosomes in dendritic cells, whereas activated mac-
rophages preserve these structures (Fig 4A and 4B). To quantify these differences, the number
of podosomes was counted based on the phalloidin staining of podosome actin cores using
ImageJ software (Fig 4E). These data confirmed that the number of podosomes is unchanged
in MDMs, but drastically decreased in MDDCs after LPS treatment. This remarkable differ-
ence in the ability of podosome formation explains the greater reduction in adhesion force of
MDDCs compared to MDMs after LPS treatment.
Fig 2. Localization and conformational state of β2-integrins. The conformational state of β2-integrins was analyzed by
confocal microscopy (A-G) and flow cytometry (H-I). Cells were incubated with the Alexa488 labelled mAb24 antibody for 20
minutes on ice, then, without washing, cells were moved to a 37˚C incubator for the indicated period of times, with or without
100 ng/ml LPS. The staining of unstimulated MDMs (A-C) and MDDCs (D-F) shows an even distribution of active β2-integrins
in the cell membrane after 5 minutes of incubation at 37˚C, whereas after 30 minutes the labelled receptors appeared in the
cytoplasm of the cell. Representative z-stack slices of MDDC (G) confirm the internalization of β2-integrins after 30 minutes at
37˚C (the bottom of the cell is shown as 0 μm). Representative pictures are shown out of 3 donors’ results. The effect of LPS
treatment on the activation state of β2-integrins was analyzed by flow cytometry. Mean fluorescence intensity (MFI) data of 4
donors are presented for MDMs (H) (mean ± SD) and 5 donors for MDDCs (I) (mean ± SD). Two-way ANOVA with
Bonferroni post-test was used to determine significant differences, � = p< 0.05; �� = p< 0.01; ��� = p< 0.001.
https://doi.org/10.1371/journal.pone.0232432.g002
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Previously we demonstrated that podosomes can be arranged in various patterns in differ-
ent cell types. In the case of MDMs we observed a belt-like or even distribution, whereas in
MDDCs clusters of podosomes appeared [12]. Here we show, that in addition to a difference
in podosome arrangement, the number of these structures is significantly lower for MDDCs
than MDMs (Fig 4E).
Differential distribution of CD11b and CD11c on the contact surface of
adherent cells after LPS treatment
Previously we demonstrated the presence of both CD11b and CD11c in the podosome adhe-
sion ring on the contact surface of MDMs and MDDCs during physiological conditions [12].
Under inflammatory conditions or upon maturation, parallel with the changes in the functions
of various cells, podosomes might be lost. In our present study we found that LPS activated
MDMs retain their ability to form podosomes with CD11b and CD11c around the actin core
(Fig 5A–5F). In LPS treated mature MDDCs however, with the loss of podosomes, CD11b and
CD11c is concentrated in the cell body around the nucleus, and in membrane ruffles on the
leading edge (Fig 5G–5L).
Both CR3 and CR4 participate in the migration of MDMs and MDDCs
The migration capacity of MDMs and MDDCs was tested using a transwell assay with a 5 μm
pore size polycarbonate membrane. To study the involvement of CD11b and CD11c, ligand
binding site specific antibodies were employed, and the number of transmigrated cells were
counted by flow cytometry.
Unstimulated MDMs and immature MDDCs are known to migrate towards N-formylated
peptides as they express formyl peptide receptors (FPRs). As a synthetic ligand N-Formyl-
methionyl-leucyl-phenylalanine (FMLP) was used, which acts similarly on FPRs as the natural
ligands. As shown in Fig 6A and 6B, both anti-CD11b and anti-CD11c reduced the number of
cells able to migrate through the membrane. For MDMs the blocking of CR3 resulted in a sig-
nificantly stronger inhibition than the blocking of CR4, while in the case of MDDCs the extent
of inhibition was the same for both receptors.
The expression of chemokine receptors and adhesion molecules, and consequently migra-
tion capacity, is influenced by the activation status of immune cells. The CCR7 chemokine
receptor appears on macrophages and DCs upon activation, therefore we used its ligand,
CCL19 as a chemoattractant to study migration under LPS induced inflammatory conditions.
Results obtained from the transwell assay show that both CR3 and CR4 participate in the
migration of the LPS treated cells (Fig 6C and 6D), and similarly to the untreated cells, block-
ing with anti-CD11b results in a somewhat stronger inhibition, when compared to the effect of
anti-CD11c, particularly in the case of unstimulated MDMs.
Fig 3. The effect of the β2-integrins’ ligand binding site specific antibodies and LPS on the adhesion to fibrinogen. (A-B) The
adhesion capacity of LPS activated MDMs (A) and MDDCs (B) was measured with the classical adhesion assay. The cells were treated
with ligand binding site specific blocking antibodies (anti-CD11b or anti-CD11c), then let to adhere on a fibrinogen coated surface. The
number of adhered cells was normalized to the isotype control antibody treated samples, shown as 100%. Results of 7 donors are shown as
mean ± SD. One-way ANOVA with Tukey’s post-test was used to determine significant differences compared to control, � = p< 0.05.
(C-F) The force of cell attachment was measured with a computer-controlled micropipette using vacuum induced fluid flow. The percent
of adhered cells was calculated by dividing the number of cells remaining on the surface after applying a given vacuum, by the number of
cells originally contained in the population. The impact of LPS treatment on the force of adhesion is shown on panel C-D. The effect of
blocking antibody treatment (anti-CD11b: white columns; anti-CD11c: black columns) on the adhesion of LPS treated cells is shown on
panel E-F. The percent of adhered cell was normalized to the isotype control antibody treated samples (shown as 100%, represented by the
dashed line). For MDMs (C, E) results of 3 donors (mean ± SD), for MDDCs (D, F) 4 donors’ results (mean ± SD) are shown. Two-way
ANOVA with Bonferroni post-test was used to determine significant differences compared to control. � = p< 0.05; �� = p< 0.01; ��� =
p< 0.001.
https://doi.org/10.1371/journal.pone.0232432.g003
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Discussion
Macrophages and dendritic cells are essential in the recognition of invading pathogens and the
initiation of immune responses. Both cell types are professional antigen presenting cells, but
they have different roles in several aspects. Dendritic cells migrate to lymph nodes after antigen
uptake to initiate an adaptive immune response by presenting these antigens to naïve T-cells
[43]. The main function of macrophages is to migrate within the peripheral tissues to the site
of infection, where they take up the antigen and eliminate pathogens by phagocytosis, produc-
tion of reactive intermediates and the establishment of an inflammatory milieu by cytokine
secretion [44].
After the lysis of Gram-negative bacteria, glycolipids from the outer membrane are released,
that serve as potent proinflammatory stimuli for myeloid cells. In vivo studies show that the
administration of bacterial lipopolysaccharides (LPS) induces acute inflammation through
eliciting the migration, cytokine production and ROS release of neutrophils and macrophages
in mice [45,46], and it also initiates the maturation of dendritic cells [47]. Studies on the envi-
ronmental effects on respiratory functions of asthma patients show that the inhalation of air-
borne endotoxins, for example in grain or house dusts, increases the severity of respiratory dis-
eases [48–50]. Endotoxins in the lungs induce an inflammatory reaction, that is characterized
by the influx of neutrophils and an elevated fibronectin production [51]. Additionally, LPS is a
major inducer of tissue injury and sepsis after a Gram-negative bacterial infection [52]. The
Fig 4. Changes in the arrangement of podosomes in the contact surface of adherent cells upon LPS treatment. The actin cytoskeleton of
adherent cells was stained with phalloidin-Alexa488 (shown in green), nuclei were stained with Draq5 DNA dye (shown in red). Both untreated
(A) and LPS treated (B) MDMs form podosomes during adhesion, whereas only untreated, immature MDDCs (C) contain these structures,
LPS treated mature MDDCs (D) lose their ability for podosome formation. The number of podosomes and cell area were measured on 40–60
cells/sample with ImageJ software (E), data are shown as podosome density (number of podosomes per 100μm2 of cell covered area). One-way
ANOVA with Tukey’s post-test was used to determine significant differences compared to control, � = p< 0.05, ��� = p< 0.001.
Representative microscopy pictures (A-D) are shown out of 5 (MDMs) or 7 (MDDCs) donors’ results and podosome density data (E) are
shown as mean ± SD of the above data.
https://doi.org/10.1371/journal.pone.0232432.g004
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overproduction of LPS-induced inflammatory mediators by mieloid cells is the leading cause
of mortality during septic shock [53,54].
LPS is known to bind to Toll-like receptors and β2-integrins that promote receptor activa-
tion and cell adhesion. Wright et al. identified an LPS binding site in the CR3 α chain that was
Fig 5. Localization of CD11b and CD11c on the contact surface changes upon LPS-treatment. MDMs (A–F) and MDDCs (G–L) were plated to a
fibrinogen coated surface, followed by staining with phalloidin-Alexa488 (A,D,G,J), anti-CD11b (B,H) or anti-CD11c (E,K). Merged images are shown in
C,F,I,L. CD11b and CD11c are located around the actin core of podosomes in LPS treated MDMs. In the case of LPS treated mature MDDCs, with the loss
of podosomes, CD11b and CD11c is concentrated in the cell body around the nucleus, and in membrane ruffles on the leading edge. Images of one
representative experiment out of 3 are shown.
https://doi.org/10.1371/journal.pone.0232432.g005
Fig 6. Analysis of the migration of MDMs and MDDCs using FMLP or CCL19 as a chemoattractant. FMLP was used as a chemoattractant for
unstimulated MDMs (A) and immature MDDCs (B), and CCL19 was applied for activated MDMs (C) and mature MDDCs (D). Cells were treated with
either anti-CD11b or anti-CD11c ligand binding site specific antibodies before migration, and the number of transmigrated cells were counted by flow
cytometry after detachment using EDTA. The number of migrated cells was normalized to the isotype control antibody treated samples, shown as 100%.
One-way ANOVA with Tukey’s post-test was used to determine significant differences compared to control, � = p< 0.05; �� = p< 0.01, ��� = p< 0.001.
https://doi.org/10.1371/journal.pone.0232432.g006
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distinct from the location of iC3b and fibrinogen binding [55]. Wong et al. identified two puta-
tive LPS binding sites in the β2 I-like domain [56] that would explain why LPS binding to
either LFA-1, CR3 or CR4 induces an inflammatory response [57–59]. CR3 was also shown to
become associated with CD14 after LPS treatment on neutrophils [60], and Ingalls et al. sug-
gested that it might use the same adaptors for LPS signaling as CD14 [61].
Antigen uptake and proinflammatory stimuli induce macrophage activation and dendritic
cell maturation involving changes in the expression of costimulatory molecules, chemokine
and phagocytic receptors [62]. Regarding neutrophil granulocytes, it is known that upon stim-
ulation by LPS they quickly, but transiently upregulate the expression of CR3 from intracellu-
lar granules, and the receptors on the cell surface switch to high affinity conformation, both
events contributing to enhanced adhesiveness [63,64].
In the present work we monitored the changes in the expression of CD11b and CD11c on
myeloid cells upon LPS stimulation and found that the appearance of these receptors is time
dependent. Namely, on MDMs and MDDCs treated with LPS for 30 minutes the amount of
CD11b slightly decreased, while the expression of CD11c did not change. After longer periods
however,–i.e. 24 and 48 hours later—the amount of CD11b decreased on both cell types. At
the same time, the quantity of CD11c increased in MDDCs but was lower in MDMs, suggest-
ing a cell type specific regulation of β2-integrin expression. Investigating their conformation,
we found a significantly elevated number of active cell membrane receptors after 30 minutes
of LPS treatment–confirmed by binding mAb24 -, due to the increased turnover of the recep-
tors. Since this antibody is specific for an activation epitope in all β2-integrins, it can recognize
LFA-1 (CD11a/CD18 or αLβ2) too. The endocytosis rate of this receptor however has been
shown to be very low compared to CR3, furthermore it is not influenced by the stimulating
agents [35]. Consequently, the increase in internalization and recycling speed observed by us
can be attributed to CR3 and CR4.
These results demonstrate that the amount of cell surface CR3 and CR4 does not increase
immediately after LPS treatment, however their activation status and recycling speed changes.
Integrin activation and recycling are most likely linked processes. Arjonen et al. showed that
active β1-integrins have a higher endocytosis rate, whereas receptors in an inactive state are
rapidly recycled to the plasma membrane [65]. Based on our data we propose that under
inflammatory conditions β2-integrin activation triggers the endocytosis as well as faster recy-
cling of these receptors. Thus, the higher endocytosis rate of CR3 in the case of LPS activated
cells explains the decrease in cell surface expression after 30 minutes.
Integrins are known to mediate cell adhesion, spreading and migration through the estab-
lishment of cell-cell and cell-extracellular matrix connections [66,67]. Our group focuses on
dissecting the individual roles of the β2-integrins CR3 and CR4, querying the assumption that
they have overlapping, or even identical functions. Early studies on human granulocytes and
monocytes proved that LFA-1, CR3 and CR4 all contribute to endothelial adhesion [68,69],
and that the cell type and the stimuli used can influence the participation of these receptors.
Georgakopoulos et al. also showed, that the involvement of CR3 and CR4 in adhesion to
fibrinogen is dependent on the experimental conditions, namely the type of stimuli and culture
conditions of human monocytes [70]. Earlier we demonstrated that in the absence of inflam-
matory stimulus CR4 plays a dominant role in the adhesion to fibrinogen [11].
Here, we studied the adhesive capacity of MDMs and MDDCs after LPS stimulation. We
used both the classical, end-point adhesion assay and a computer-controlled micropipette
method capable of measuring the force of adhesion [71]. When applying ligand binding site
specific antibodies, we found that both anti-CD11b and anti-CD11c treatment weakened the
adhesion to fibrinogen coated surfaces, as verified by the decreased number of adherent cells
as well as the force of attachment. Importantly however, while both receptors participated in
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adhesion, the force of attachment was significantly lower for the anti-CD11c treated cells in
the case of MDDCs, proving a dominant role for CR4 on this cell type.
This differential participation of CR3 and CR4 in adhesion confirms our previous hypothe-
sis [11], namely that ligand availability and the number of cell surface receptors regulates
receptor utilization. Based on the absolute number of cell surface receptors [9,11] we proved
that there is a competition for accessible fibrinogen ligands between CR3 and CR4 on MDMs
and MDDCs, where both receptors are present in high amounts. On monocytes however, both
receptors took part in adherence, because their amount is comparable with the number of
fibrinogen ligands. Since LPS treatment altered the cell surface expression of these receptors
differently on MDMs and MDDCs, we detected a change in receptor usage. On MDMs the
number of both receptors decreased upon LPS treatment, allowing the ligand binding by both
CR3 and CR4. In the case of MDDCs the ratio of cell membrane receptors shifts in favor of
CR4, strengthening its dominant role.
Emerging data on podosomes highlight their importance in myeloid cell adhesion and
migration. Considering the differences in immune functions of macrophages and dendritic
cells we compared the formation and β2-integrin composition of podosomes after inflamma-
tory stimuli on these cell types. During LPS induced maturation dendritic cells go through
cytoskeletal changes, losing their capacity for phagocytosis and podosome formation
[25,72,73]. Van Helden et al. showed that in human DCs the loss of podosomes is rapidly (5–
10 minutes) induced by prostaglandins, but it takes at least 16 hours after LPS treatment
through the engagement of TLR4 and the induction of prostaglandin production. At the same
time the migration speed of mature human DCs increases without the constraint of strong
podosome contacts [34,74]. In mouse DCs however, LPS induces a quick, but transient change.
TLR signals enhance phagocytosis and antigen sampling, during which cells switch from
podosome formation to focal contacts, losing their ability to migrate. Two hours after LPS
stimulus podosomes become prominent again, and the migration speed of DCs is restored
[33,75]. In this study we confirm, that after 24 hours of LPS treatment MDDCs do not form
podosomes on a fibrinogen coated surface, significantly lowering the force of adherence com-
pared to immature cells. In contrast, MDMs preserve these structures after LPS activation and
there is only a slight decrease in the adhesion force measured with the computer-controlled
micropipette, proving that podosomes ensure a strong attachment.
It is well established that integrin activation is necessary for cell attachment, but their coor-
dinated inactivation is also essential to maintain directional migration [76]. Semmerich et al.
showed with a constitutively active LFA-1 mutation in mice, that integrin deactivation is
needed for the detachment from the adhesive surface to sustain cell movement [77]. Van Hel-
den et al. also showed, that through the inactivation of α5β1 integrin DCs have an increased
migration speed, establishing only short lived, weaker adhesion spots with the fibronectin sub-
stratum [34]. A crucial and specific role for β2-integrins in podosome functions has been dem-
onstrated by others [25,26], and we have also proven, that under physiological conditions both
CR3 and CR4 are located in the adhesion ring of podosomes in human MDMs and MDDCs
attached to fibrinogen [12]. Here we show that in the case of LPS activated MDMs, the cells
become more elongated, but CD11b and CD11c are localized around the actin core of podo-
somes, similarly to untreated cells. On LPS matured MDDCs, with the loss of podosomes,
CD11b and CD11c are concentrated in the cell body and in membrane protrusions. Although
our results indicate that LPS treatment enhances β2-integrin activation at the early timepoints
of cell activation (30–60 minutes), the loss of podosomes is associated with changes in the dis-
tribution of CR3 and CR4 that might influence the adhesive and migratory capacity of DCs.
Podosomes are proposed to participate in cell migration, but their exact role is not yet
established. The experiments presented by van Helden et al. showed a faster migration speed
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of human DCs after podosome loss, but it was studied with an assay using a 2D surface [34]. In
mice, West et al. showed with a transwell assay, that DCs do not migrate without podosomes
[33]. Later van den Dries et al. provided evidence, that the dissolution of podosomes is depen-
dent on the structure of the environment, the disassembly of podosomes is quickly accom-
plished on a 2D surface after prostaglandin E2 treatment, but it is inhibited in a 3D
environment [78]. Considering these data and the matrix degrading ability of podosomes,
these structures are more likely to be important for 3D migration and extravasation, which is
slowed in their absence.
In our experiments, the migratory capacity of unstimulated and LPS treated MDMs and
MDDCs was also assessed by a transwell assay using the well described chemoattractants
FMLP and CCL19. We used ligand binding site specific blocking antibodies to determine the
participation of CR3 and CR4 in transmigration. Although both anti-CD11b and anti-CD11c
inhibited the migration of unstimulated MDMs towards FMLP, the number of migrated cells
was significantly lower when CR3 was blocked. In the case of immature MDDCs both recep-
tors took part equally. On the LPS treated MDMs and MDDCs, both receptors were found to
contribute to the migration in the direction of CCL19.
Our previous studies proved a “division of labor” between CR3 and CR4 under physiologi-
cal conditions [11,12]. We demonstrated that CR3 participates in the phagocytosis of iC3b
opsonized Staphylococcus aureus, while CR4 dominates cell adhesion to fibrinogen. During
inflammatory conditions the distinct role of these β2-integrins has not been systematically
investigated before. Our present data show that after LPS treatment the expression and role of
these receptors considerably changes, proving our previous hypothesis, that the number and
ratio of cell surface receptors influences the outcome of cell-matrix interactions. Our findings
underline the functional differences between macrophages and dendritic cells, and emphasize
the essential role of podosomes for firm cell attachment.
Supporting information
S1 Fig. Changes in the expression of CR3 and CR4 after LPS induced activation. The sur-
face expression of CR3 and CR4 was measured at different time points by flow cytometry. Rep-
resentative histograms were chosen from 3 (MDMs) and 4 (MDDCs) donors’ results.
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